| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | J05AF01 |
| UNII | 4B9XT59T7S |
| EPA CompTox | DTXSID8020127 |
| InChI Key | HBOMLICNUCNMMY-XLPZGREQSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C10H13N5O4 |
| Molecular Weight | 267.25 |
| AlogP | -0.2 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 133.08 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase inhibitor | INHIBITOR | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
2-38 | 3-50 | 5.4 | - | 0-96 | |
|
Enzyme
Protease
Aspartic protease
Aspartic protease AA clan
Aspartic protease A2A subfamily
|
126 | 6-23 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 4.7-134.05 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | - | - | - | 4.7 |
| Resources | Reference |
|---|---|
| ChEBI | 10110 |
| ChEMBL | CHEMBL129 |
| DrugBank | DB00495 |
| DrugCentral | 2861 |
| FDA SRS | 4B9XT59T7S |
| Human Metabolome Database | HMDB0014638 |
| Guide to Pharmacology | 4825 |
| KEGG | C07210 |
| PDB | AZZ |
| PharmGKB | PA451954 |
| PubChem | 35370 |
| SureChEMBL | SCHEMBL7409 |
| ZINC | ZINC000003779042 |